Zentasta

Zentasta combines ezetimibe and atorvastatin calcium trihydrate to support cholesterol management. This oral medication is used alongside diet to address lipid levels. Commonly prescribed for high cholesterol and related cardiovascular risks. Suitable for adults seeking combined therapy.

Zentasta is prescribed to help lower LDL cholesterol, triglycerides, and increase HDL cholesterol when lifestyle changes alone are insufficient. It combines two active ingredients: ezetimibe, which reduces cholesterol absorption in the intestines, and atorvastatin, which decreases cholesterol production in the liver. This dual-action approach is often used for patients with primary hyperlipidemia or mixed dyslipidemia. It may also be used to reduce the risk of heart disease in certain high-risk individuals.

Users may notice improved cholesterol levels within weeks of starting Zentasta. Some individuals report reduced fatigue or improved energy levels as cholesterol stabilizes. The medication works gradually, supporting overall cardiovascular health over time. Regular monitoring is recommended to assess progress and adjust therapy as needed.

Zentasta should be taken exactly as prescribed by a healthcare provider. It is important to follow a heart-healthy diet and exercise plan while using this medication. People with liver disease or unexplained high liver enzymes should use this medication with caution. Pregnant or breastfeeding individuals should consult a doctor before use.

Zentasta may interact with other medications that affect liver enzymes, such as certain antifungals or HIV treatments. Grapefruit juice can increase the risk of side effects and should be avoided. Alcohol use may enhance liver-related side effects. Always inform your healthcare provider about all medications and supplements you are taking.